Calithera Biosciences Inc...
(CALA)
undefined
undefined%
At close: undefined
0.03
9900.00%
Pre-market Jan 12, 2024, 09:30 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | n/a | 9.75M | n/a | n/a | 22.25M | 25.95M | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 1.39M | 1.43M | 1.87M | 1.84M | n/a | n/a | 297.00K | n/a | n/a | n/a | n/a |
| Gross Profit | -1.39M | 8.32M | -1.87M | -1.84M | 22.25M | 25.95M | -297.00K | n/a | n/a | n/a | n/a |
| Operating Income | -42.07M | -115.43M | -91.39M | -92.89M | -57.28M | -29.69M | -38.33M | -32.82M | -21.72M | -12.38M | -7.97M |
| Interest Income | n/a | 345.00K | 1.25M | 3.04M | 2.65M | 1.86M | 330.00K | 175.00K | n/a | n/a | n/a |
| Pretax Income | -39.65M | -115.09M | -90.14M | -89.86M | -54.63M | -27.83M | -38.00M | -32.64M | -21.71M | -12.38M | -7.97M |
| Net Income | -18.87M | -165.34M | -88.52M | -86.35M | -51.47M | -27.83M | -38.00M | -32.64M | -21.71M | -12.38M | -7.97M |
| Selling & General & Admin | 12.16M | 20.85M | 20.37M | 16.61M | 13.34M | 12.53M | 10.59M | 9.07M | 5.35M | 2.48M | 1.42M |
| Research & Development | 28.53M | 53.45M | 71.02M | 76.29M | 66.19M | 43.11M | 27.75M | 23.75M | 16.37M | 9.90M | 6.56M |
| Other Expenses | n/a | 50.88M | n/a | n/a | n/a | n/a | n/a | n/a | 9.00K | 1K | n/a |
| Operating Expenses | 40.69M | 74.31M | 91.39M | 92.89M | 79.53M | 55.64M | 38.33M | 32.82M | 21.72M | 12.38M | 7.97M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | -1.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 42.07M | 74.31M | 91.39M | 92.89M | 79.53M | 55.64M | 38.33M | 32.82M | 21.72M | 12.38M | 7.97M |
| Income Tax | -20.78M | 50.25M | -1.61M | -3.51M | -3.16M | -365.00K | -297.00K | -404.00K | -361.00K | n/a | n/a |
| Shares Outstanding (Basic) | 4.99M | 3.69M | 3.44M | 2.37M | 1.83M | 1.65M | 974.30K | 902.25K | 232.60K | 394.69K | 394.69K |
| Shares Outstanding (Diluted) | 4.99M | 3.69M | 3.44M | 2.37M | 1.83M | 1.65M | 974.30K | 902.25K | 232.60K | 394.69K | 394.69K |
| EPS (Basic) | -7.94 | -44.77 | -25.73 | -36.5 | -28.12 | -16.89 | -39.01 | -36.18 | -93.34 | -31.36 | -20.21 |
| EPS (Diluted) | -7.94 | -44.77 | -25.73 | -36.5 | -28.12 | -16.89 | -39.01 | -36.18 | -93.34 | -31.36 | -20.21 |
| EBITDA | -38.27M | -115.43M | -88.27M | -88.02M | -57.28M | -29.69M | -37.71M | -32.24M | -21.35M | -12.10M | -4.82M |
| Depreciation & Amortization | 1.39M | 1.43M | 1.87M | 1.84M | 505.00K | 365.00K | 297.00K | 404.00K | 361.00K | 281.00K | 269.00K |